| RS150230201 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS150230845 |
PNPLA6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 39, Hereditary spastic paraplegia 39 |
| RS150231219 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS150231327 |
FANCI
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group I |
| RS150232843 |
MFRP
|
Health Risk |
Pathogenic |
Isolated microphthalmia 5, Retinal dystrophy |
| RS150233337 |
TBX4
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS150233690 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, 6 conditions |
| RS150233736 |
KLHL41
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 9, Inborn genetic diseases |
| RS150236371 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS150237160 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS150237416 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Connective tissue disorder |
| RS150238159 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150239235 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS150239404 |
CWF19L1
|
Health Risk |
Pathogenic |
— |
| RS150239870 |
DZIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150241349 |
PLCB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 12 |
| RS150241539 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, MYH7-related skeletal myopathy |
| RS150242262 |
CPLANE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS150242481 |
WNT4
|
Health Risk |
Conflicting classifications of pathogenicity |
Mullerian aplasia and hyperandrogenism, SERKAL syndrome |
| RS150242638 |
COL27A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150242757 |
FGG
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital afibrinogenemia, FGG-related disorder |
| RS150243147 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
COQ8A-related disorder, COQ8A-related disorder |
| RS150244426 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease |
| RS150244667 |
ASL
|
Health Risk |
Pathogenic/Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS150245906 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Naxos disease, Arrhythmogenic right ventricular dysplasia 12 |
| RS150245955 |
GJB3
|
Health Risk |
Conflicting classifications of pathogenicity |
GJB3-related disorder, Inborn genetic diseases |
| RS150246251 |
IFT172
|
Health Risk |
Pathogenic/Likely pathogenic |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS150246328 |
SI
|
Health Risk |
Conflicting classifications of pathogenicity |
Sucrase-isomaltase deficiency, SI-related disorder |
| RS150246404 |
GLE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital contracture syndrome 1, Lethal arthrogryposis-anterior horn cell disease syndrome |
| RS150246870 |
SLC16A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Exercise-induced hyperinsulinism, Exercise-induced hyperinsulinism |
| RS150247275 |
BEST1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, BEST1-related disorder |
| RS150248483 |
SYN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, X-linked 1 |
| RS150248865 |
ELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Supravalvar aortic stenosis, Cutis laxa |
| RS150248985 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, Inborn genetic diseases |
| RS150250100 |
OBSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 2, OBSL1-related disorder |
| RS150250182 |
ILDR1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150250443 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS150252937 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, Autoinflammatory syndrome |
| RS150253422 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS150254629 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS150254933 |
CHRNA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nocturnal frontal lobe epilepsy 4, Autosomal dominant nocturnal frontal lobe epilepsy |
| RS150255203 |
GBF1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150255709 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiovascular phenotype |
| RS150258541 |
SLC12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Bartter disease type 1 |
| RS150259543 |
PIGG
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal recessive 53 |
| RS150260103 |
CNGB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Achromatopsia 3, Severe early-childhood-onset retinal dystrophy |
| RS150260489 |
RPE65
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 2, Retinitis pigmentosa 20 |
| RS150260759 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS150260969 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS150261092 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia type 2A |
| RS150261456 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kartagener syndrome, Primary ciliary dyskinesia |
| RS150262490 |
DCHS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150262900 |
HPS3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS150263014 |
SEC23B
|
Health Risk |
Pathogenic |
Congenital dyserythropoietic anemia, type II |
| RS150263699 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS150264233 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Death in infancy |
| RS150266274 |
PGM1
|
Health Risk |
Conflicting classifications of pathogenicity |
PGM1-congenital disorder of glycosylation, PGM1-related disorder |
| RS150266349 |
ANKRD1
|
Health Risk |
Conflicting classifications of pathogenicity |
ANKRD1-related dilated cardiomyopathy, Cardiovascular phenotype |
| RS150266354 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS150266932 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150268130 |
HNF1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young, Maturity-onset diabetes of the young |
| RS150269540 |
TTC7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Common variable immunodeficiency, Multiple gastrointestinal atresias |
| RS150270086 |
LYST
|
Health Risk |
Conflicting classifications of pathogenicity |
Chédiak-Higashi syndrome, Inborn genetic diseases |
| RS150271870 |
GCDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Glutaric aciduria, type 1 |
| RS150271893 |
NTRK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary insensitivity to pain with anhidrosis, Hereditary cancer |
| RS150271983 |
ODAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS150272167 |
ALG1
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG1-congenital disorder of glycosylation, ALG1-congenital disorder of glycosylation |
| RS150272676 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Inborn genetic diseases |
| RS150273659 |
SFTPA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Interstitial lung disease 2, SFTPA2-related disorder |
| RS150273938 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150276786 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
Saldino-Mainzer syndrome, Retinitis pigmentosa 80 |
| RS150277124 |
KMT2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150277901 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150277911 |
ITGB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Junctional epidermolysis bullosa with pyloric atresia, Epidermolysis bullosa |
| RS150278938 |
NDUFS8
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS150279202 |
OPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant optic atrophy classic form, OPA1-related disorder |
| RS150279426 |
ENPP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arterial calcification, generalized |
| RS150279909 |
PCNT
|
Health Risk |
Conflicting classifications of pathogenicity |
PCNT-related disorder, PCNT-related disorder |
| RS150280414 |
KIF1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic ataxia 2, Inborn genetic diseases |
| RS150280452 |
C5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150280500 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinal dystrophy |
| RS150280940 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Autoinflammatory syndrome |
| RS150280970 |
LINS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS150281463 |
CDK4
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS150283105 |
ACAD9
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Mitochondrial complex I deficiency |
| RS150283412 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tangier disease, Hypoalphalipoproteinemia |
| RS150284288 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS150284394 |
C1QTNF5;MFRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Isolated microphthalmia 5, Late-onset retinal degeneration |
| RS150284621 |
MSX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tooth agenesis, selective |
| RS150284749 |
CACNA2D2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, Inborn genetic diseases |
| RS150284874 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS150285174 |
IL12RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency, Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency |
| RS150285287 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Distal myopathy with posterior leg and anterior hand involvement |
| RS150285580 |
MICAL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS150285674 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |
| RS150286262 |
ARFGEF1
|
Health Risk |
Pathogenic |
DEVELOPMENTAL DELAY, IMPAIRED SPEECH |
| RS150286306 |
CARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 27, Inborn genetic diseases |
| RS150286673 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Autosomal dominant cerebellar ataxia |
| RS150287359 |
KL
|
Health Risk |
Conflicting classifications of pathogenicity |
Tumoral calcinosis, hyperphosphatemic |
| RS150288279 |
PRODH
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Proline dehydrogenase deficiency |